Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
D287770-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $216.90 | |
D287770-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $484.90 | |
D287770-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $890.90 | |
D287770-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $1,533.90 | |
D287770-250mg | 250mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $3,451.90 |
Potent TLR7 agonist
Synonyms | 1059070-10-8|DSR-6434|6-Amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]-3-pyridinyl]methyl]-7,9-dihydro-8H-purin-8-one|DSR 6434|8YBW739LJ0|CHEMBL2315158|6-amino-2-(butylamino)-9-((6-(2-(dimethylamino)ethoxy)pyridin-3-yl)methyl)-7,9-dihydro-8h-purin-8 |
---|---|
Specifications & Purity | ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Potent TLR7 agonist (EC50= 7.2 nM). Activates several immune effector cellsin vitro. Suppresses metastasisin vivoand enhances efficacy of radiation therapy in a model of colorectal carcinoma. |
Storage Temp | Protected from light,Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Product Description | Product description DSR-6434 is a potent and selective Toll-like receptor 7 (TLR7) agonist, with EC50s of 7.2 nM and 4.6 nM for human and mice TLR7, respectively. DSR-6434 has a strong antitumor effect. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 6-amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]pyridin-3-yl]methyl]-7H-purin-8-one |
---|---|
INCHI | InChI=1S/C19H28N8O2/c1-4-5-8-21-18-24-16(20)15-17(25-18)27(19(28)23-15)12-13-6-7-14(22-11-13)29-10-9-26(2)3/h6-7,11H,4-5,8-10,12H2,1-3H3,(H,23,28)(H3,20,21,24,25) |
InChi Key | SSZHESNDOMBSRV-UHFFFAOYSA-N |
Canonical SMILES | CCCCNC1=NC(=C2C(=N1)N(C(=O)N2)CC3=CN=C(C=C3)OCCN(C)C)N |
Isomeric SMILES | CCCCNC1=NC(=C2C(=N1)N(C(=O)N2)CC3=CN=C(C=C3)OCCN(C)C)N |
PubChem CID | 25071151 |
Molecular Weight | 400.48 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
A2419649 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419648 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419650 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419651 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419652 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419653 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419654 | Certificate of Analysis | Jan 08, 2024 | D287770 |
B2419655 | Certificate of Analysis | Jan 08, 2024 | D287770 |
Solubility | Solvent:1eq. HCl, Max Conc. mg/mL: 20.02, Max Conc. mM: 50; Solvent:DMSO, Max Conc. mg/mL: 40.05, Max Conc. mM: 100 |
---|---|
Sensitivity | light sensitive |